|
Assay test
|
Species
|
N/E
|
nSe + nSp
|
Antigens
|
Se (%)
|
Sp (%)
|
References
|
|---|
|
Skin test (CFT)
|
Wild bison
|
N
|
ND
|
bPPD
|
57.6
|
80.3
|
[105]
|
| |
Wild bison
|
N
|
2 + 24
|
bPPD
|
50
|
88
|
[111]
|
|
Skin test (SCITT)
|
African buffalo
|
N
|
51
|
bPPD, aPPD
|
86.3
|
NE
|
[88]
|
|
IGRA
|
African buffalo
|
N + E
|
149 + 344
|
bPPD, aPPD
|
92.1
|
68.3
|
[81]
|
|
African buffalo
|
N
|
8
|
bPPD, aPPD
|
100
|
NE
|
[7]
|
|
PC-HP, PC-EC
|
75
|
NE
|
| |
African buffalo
|
N
|
44
|
ESAT-6, CFP-10, TB-7.7
|
71
|
NE
|
[86]
|
|
PC-EC
|
91
|
NE
|
|
PC-HP
|
95
|
NE
|
| |
African buffalo
|
N
|
51 + 70
|
ESAT-6, CFP-10, TB-7.7
|
80.4
|
100
|
[88]
|
|
IP-10 assay
|
African buffalo
|
N
|
44 + 40
|
PC-HP
|
93.2
|
90
|
[86]
|
|
PC-EC
|
81.8
|
92.5
|
|
ESAT-6, CFP-10, TB-7.7
|
86.4
|
92.5
|
| |
African buffalo
|
N
|
32 + 39
|
ESAT-6, CFP-10, TB-7.7
|
94
|
92
|
[87]
|
| |
African buffalo
|
N
|
51 + 70
|
ESAT-6, CFP-10, TB-7.7
|
88.2
|
100
|
[88]
|
|
MAPIA
|
Wild bison
|
N
|
12 + 70
|
M. bovis antigensa
|
92
|
97
|
[111]
|
|
FPA
|
Wild bison
|
N
|
ND
|
MPB70
|
4.4
|
83.2
|
[105]
|
|
Wild bison
|
N
|
9 + 57
|
MPB70
|
67
|
34
|
[111]
|
|
Idexx ELISA
|
African buffalo
|
N
|
8
|
bPPD
|
37.5
|
NE
|
[7]
|
|
BovidTB STAT-PAK
|
African buffalo
|
N
|
100 + 100
|
ESAT-6, CFP-10, MPB83
|
33
|
90
|
[114]
|
|
VetTB STAT-PAK
|
Wild bison
|
N
|
ND
|
ESAT-6, CFP-10, MPB83
|
12.7
|
98.4
|
[105]
|
|
RT1
|
African buffalo
|
N
|
100 + 100
|
NM
|
23
|
94
|
[114]
|
|
RT2
|
Wild bison
|
N
|
12 + 70
|
ESAT-6, CFP-10, MPB83
|
67
|
99
|
[111]
|
- N/E: natural or experimental infection; nSe: number of TB positive animals used for evaluation of Se; nSp: number of TB negative animals used for evaluation of Sp; Se: sensitivity; Sp: specificity; CFT: caudal fold test; SCITT: single comparative intradermal tuberculin skin test; IGRA: interferon gamma release assay; IP-10: interferon gamma-inducible protein 10; PC-EC: contains ESAT-6- and CFP-10-derived peptides; PC-HP contains ESAT-6- and CFP-10-derived peptides and 4 mycobacterial antigens (including Rv3615); MAPIA: multiantigenimmunoprint assay; FPA: fluorescent polarization assay; ELISA: enzyme linked immunosorbent assay; Idexx ELISA: commercial ELISA (Idexx Laboratories, Inc., Westbrook, ME, USA); Bovid TB STAT-PAK and DPP Vet TB: lateral flow tests (Chembio Diagnostic Systems, Inc., USA); RT1: rapid test (Anigen, Animal Genetics, Inc., South Korea-name of the test not mentioned); RT2: lateral flow rapid test (Chembio Diagnostic Systems, Inc., USA); NE: not estimated; NM: not mentioned; ND: not defined, Se and Sp estimated based on Bayesian analysis (absence of gold standard).
- a ESAT-6, CFP-10, MPB59, MPB64, MPB70, MPB83, the16-kDa protein, the 38-kDa protein, two fusion proteins comprising CFP-10/ESAT-6 and the 16 kDa protein/MPB83, and two native antigens, bovine PPD and M. bovis culture filtrate.